The Peregrine Post-Market Study for the Treatment of Hypertension

NCT02570113 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ablative Solutions, Inc.